FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:737-738 February 17, 2005 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Second edition. Edited by Sheila J. Wallace and Kevin Farrell. 497 pp., illustrated. London, Arnold, 2004. $168.75. ISBN 0-340-80814-4.

Estimates of the prevalence of epilepsy — which is defined as two or more unprovoked seizures or a condition for which antiepileptic medications have been used, in either case within the past five years — range from 0.5 to 1 percent of the population. Thus, at present, approximately 2 million persons in the United States have epilepsy. The incidence of epilepsy rises first gradually and then more rapidly after the third decade of life as the causes of symptomatic seizures, such as stroke and brain tumors, become more common. An exception to this trend of steady increase is the first . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.